Navigation Links
Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
Date:9/4/2008

ct #785P) A. Hoos - Poster presentation and discussion from 12:45 p.m. to 1:45 p.m. local time on Saturday, September 13, 2008.

-- "Effect of dose on efficacy and safety in ipilimumab-treated patients with advanced melanoma - results from a Phase 2, randomized, dose-ranging study" (Abstract #769O) C. Lebbe - Oral presentation from 3:30 p.m. to 5:30 p.m. local time on Monday, September 15, 2008.

-- "Efficacy and safety of treatment-naive and previously treated patients with advanced melanoma receiving ipilimumab" (Abstract #778PD) R. Ridolfi - Poster discussion from 12:30 p.m. to 1:30 p.m. local time on Monday, September 15, 2008.

-- "Efficacy and safety of ipilimumab in patients with advanced melanoma who had progressed on one or more prior therapies: results from a single-arm, multicenter study" (Abstract #776PD) M. Maio - Poster discussion from 12:30 p.m. to 1:30 p.m. local time on Monday, September 15, 2008.

-- "Prolonged stable disease in ipilimumab-treated patients with advanced melanoma who have progressed on prior anticancer therapies" (Abstract #768O) V. Chiarion Sileni - Oral presentation from 3:30 p.m. to 5:30 p.m. local time on Monday, September 15, 2008.

More information about the ESMO Congress may be found at http://www.esmo.org.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in hum
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
8. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
9. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Texas , July 28, 2015 ... Dermatology Devices Market by Type (Dermatology Treatment Devices, and ... Dermatoscopes, Microscopes]), by Application, by Geography - Analysis and ... expected to reach $11.88 billion by 2019, at a ... Browse through the TOC of Global Dermatology Devices Market ...
(Date:7/28/2015)...   Vincari , known for their Lightspeed ... John O,Neil as their Executive Vice President ... years of diverse and progressive experience within the healthcare ... coupled with Vincari,s CMO, Dr. Lucian Newman,s ... the challenges both hospitals and surgeons face, including the ...
(Date:7/28/2015)... , July 28, 2015 Research and ... of the "Global Hearing Aids Market 2015-2019" ... The global hearing aids market to grow at ... Factors such as changing demographics ... market growth. The market has witnessed immense technological ...
Breaking Medicine Technology:Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... Obama’s visit to Ethiopia to learn more about the impact of U.S. collaborations ... This initiative focuses on accelerating agricultural development as an engine of broad-based economic ...
(Date:7/28/2015)... ... 16, 2015 (PRWEB) July 28, 2015 , ... Nations Insurance ... insurance quotes to its clients, recently announced the launch of Commercial, Auto and ... their specific needs. , Liability automobile insurance policies are one popular type ...
(Date:7/28/2015)... ... 2015 , ... Women in Technology (WIT), the premier organization contributing to the ... has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the organization’s ... this organization that empowers women to thrive and excel in the technology field. In ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently ... talk took place from noon to 1 p.m. Tuesday, June 23, at the Gulf ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... WASHINGTON, June 15 Speaker Nancy Pelosi issued the ... the American Medical Association, in which he clearly described the ... "President Obama made a clear and compelling case today for ... uniquely American solution for quality, affordable health care right now. ...
... Escalating funding issues challenge social service providers in ... indicate that decreasing funds impact both those they serve ... new budget years a stark reality has emerged. ... but essential, services to the country,s poor and most ...
... that an alpha-particle emitting radiopeptideradioactive material bound to a ... prostate cancer in mice, according to researchers at SNM,s ... result in a significant breakthrough in prostate cancer treatment, ... is removed. "Our study shows that this ...
... The following was released today by the National Council on ... Council on Aging (NCOA), along with leading health care experts, ... adults with multiple chronic health conditions at their briefing ... Reform . The Capitol Hill briefing will highlight ...
... Md., June 15 Take Shape For Life, the personal coaching ... a record number of independent Health Coaches at its annual National ... held at The Phoenician in Scottsdale, AZ from July 9th to ... 1,200 Take Shape For Life Health Coaches represents a 60 percent ...
... students rose from 1,440 deaths in 1998 to 1,825 in ... according to an article in the July supplement of the ... The special issue describes the results of a ... problems at campuses across the country. These studies resulted ...
Cached Medicine News:Health News:Government Must Not Balance Budget on the Backs of the Poor 2Health News:Government Must Not Balance Budget on the Backs of the Poor 3Health News:New approach for treating recurrent prostate cancer on the horizon 2Health News:National Survey Reveals a Broken System for Chronic Disease Sufferers; National Council on Aging and Health Experts Explore Self-Care as a Viable, Consumer Focused Option for Health Reform 2Health News:Take Shape For Life Expecting Record Attendance at 2009 National Convention 2Health News:As college drinking problems rise, new studies identify effective prevention strategies 2Health News:As college drinking problems rise, new studies identify effective prevention strategies 3
... The TandemHeart PTVA ( Percutaneous ... unique proprietary solution for the hemodynamic needs ... Cardiologists and Cardiac Surgeons. These specialists ... provide some coronary artery perfusion, but the ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
... Line catheter is inserted into the subclavian ... superior vena cava. The Cool Line ... sterile, temperature-controlled saline flowing within a closed-loop ... central circulation. The Cool Line combines ...
...
Medicine Products: